http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-341176-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
filingDate 2010-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3005b18a2d7006043b72e33c16209535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ab5bc0701f45477855cad227f870d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e43af1706fd41ad61833eb150cd8b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a482b0307962a95a822a1bf6ee2121d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb2cc124132f0f3bc3b4cb7c41c61c88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7637064536620d90d980a4350311254
publicationDate 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-341176-B
titleOfInvention CARBOXAMIDE COMPOUNDS AND ITS USE AS CALPAINE INHIBITORS.
abstract The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. Carboxamide compounds are inhibitors of calpain (calcium-dependent cysteine proteases). Therefore, the invention also relates to the use of said carboxamide compounds to treat a disorder associated with high calpain activity. Carboxamide compounds are compounds of the general formula I, wherein R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the salts thereof suitable for pharmaceutical use. In particular, the compounds have the general formula e and Ib, where R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including tautomers thereof and pharmaceutically salts. appropriate of them. Of said compounds, those where Y is a CH2-CH2, CH2-CH2-CH2, N (RY #) - CH2, N (RY #) - CH2-CH2 or CH = CH-CH unit are preferred in each of which optionally 1 or 2 atoms of H have been replaced by identical or different RY radicals, where RY # and RY # have the meanings mentioned in the claims.
priorityDate 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27730

Total number of triples: 65.